Literature DB >> 2558163

Detection of defective genomes in hepatitis A virus particles present in clinical specimens.

J P Nüesch1, J de Chastonay, G Siegl.   

Abstract

Hepatitis A virus (HAV) particles harbouring a physically defective RNA genome have been reported to occur in all HAV-infected cell culture systems analysed so far. The most prominent defects consist of three distinct overlapping deletions in the region of the HAV genome encoding the structural proteins. By probing for the endpoints of these deletions in RNA samples using S1 nuclease and exonuclease VII mapping, we obtained suggestive evidence for the existence also of defective genomes in HAV particles present in faecal specimens, in viraemic blood collected in the course of hepatitis A virus infection in man, as well as in the liver of an experimentally infected marmoset monkey. The deletions identified extend from nucleotide (nt) 1200 to nt 3820 and from nt 1200 to nt 3240 of the HAV genome. They are compatible with two of the deletions detected in particles grown in vitro in cell cultures and shown to interfere with the replication of standard hepatitis A virions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2558163     DOI: 10.1099/0022-1317-70-12-3475

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

Review 1.  Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?

Authors:  Nigel J Dimmock; Andrew J Easton
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

2.  Excretion of hepatitis A virus (HAV) in adults: comparison of immunologic and molecular detection methods and relationship between HAV positivity and infectivity in tamarins.

Authors:  L B Polish; B H Robertson; B Khanna; K Krawczynski; J Spelbring; F Olson; C N Shapiro
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

3.  Replication of subgenomic hepatitis A virus RNAs expressing firefly luciferase is enhanced by mutations associated with adaptation of virus to growth in cultured cells.

Authors:  MinKyung Yi; Stanley M Lemon
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

4.  Truncated particles produced in fish surviving infectious hematopoietic necrosis virus infection: mediators of persistence?

Authors:  C H Kim; D M Dummer; P P Chiou; J A Leong
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

5.  Defective interfering viral particles in acute dengue infections.

Authors:  Dongsheng Li; William B Lott; Kym Lowry; Anita Jones; Hlaing Myat Thu; John Aaskov
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

6.  Defective viral genomes arising in vivo provide critical danger signals for the triggering of lung antiviral immunity.

Authors:  Karla Tapia; Won-Keun Kim; Yan Sun; Xiomara Mercado-López; Emily Dunay; Megan Wise; Michael Adu; Carolina B López
Journal:  PLoS Pathog       Date:  2013-10-31       Impact factor: 6.823

Review 7.  Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: From Synthetic PRR Agonists to the Potential of Defective Interfering Particles of Viruses.

Authors:  Andri Vasou; Nazife Sultanoglu; Stephen Goodbourn; Richard E Randall; Leondios G Kostrikis
Journal:  Viruses       Date:  2017-07-13       Impact factor: 5.048

Review 8.  Effects of defective interfering viruses on virus replication and pathogenesis in vitro and in vivo.

Authors:  L Roux; A E Simon; J J Holland
Journal:  Adv Virus Res       Date:  1991       Impact factor: 9.937

9.  Low-Fidelity Polymerases of Alphaviruses Recombine at Higher Rates To Overproduce Defective Interfering Particles.

Authors:  Enzo Z Poirier; Bryan C Mounce; Kathryn Rozen-Gagnon; Peter Jan Hooikaas; Kenneth A Stapleford; Gonzalo Moratorio; Marco Vignuzzi
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

10.  A Defective Interfering Influenza RNA Inhibits Infectious Influenza Virus Replication in Human Respiratory Tract Cells: A Potential New Human Antiviral.

Authors:  Claire M Smith; Paul D Scott; Christopher O'Callaghan; Andrew J Easton; Nigel J Dimmock
Journal:  Viruses       Date:  2016-08-22       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.